40
Participants
Start Date
September 13, 2021
Primary Completion Date
June 26, 2023
Study Completion Date
June 26, 2023
ALXN1840
Administered as an oral tablet.
Standard of Care
Depending on the site/region, participants randomized to receive Standard of Care treatment will receive trientine, penicillamine, zinc, or a combination of these medicines, administered according to standard regimens.
Research Site, South Brisbane
Research Site, Esplugues de Llobregat
Research Site, Madrid
Research Site, Málaga
Research Site, Hanover
Research Site, Pamplona
Research Site, Toulouse
Research Site, Las Palmas de Gran Canaria
Research Site, Lille
Research Site, Tübingen
Research Site, Parkville
Research Site, Kumamoto
Research Site, Kurume-shi
Research Site, Meguro-ku
Research Site, Sapporo
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY